Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Joy

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Neurosurgical Focus|November 2, 2022
Outcomes following stereotactic radiosurgery for foramen magnum meningiomas: a single-center experience and systematic review of the literatureConstantine L Karras, Pavlos Texakalidis, Jeffrey Z Nie, et al.
Pharmacotherapy|March 16, 2005
Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical PharmacyAlan J Zillich, Joseph J Saseen, Renee M Dehart, et al.
International Journal of Molecular Sciences|November 27, 2024
Population Pharmacokinetic Model of Vitamin D<sub>3</sub> and Metabolites in Chronic Kidney Disease Patients with Vitamin D Insufficiency and DeficiencyStacey M Tuey, Avisek Ghimire, Serge Guzy, et al.
Journal of Clinical Microbiology|March 9, 2004
Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United StatesS Joy Milan, Kirsten A Hauge, Natalia E Kurepina, et al.
Journal of Clinical Pharmacology|June 9, 2022
The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney DiseaseStacey M Tuey, Linda Prebehalla, Amandla-Atilano Roque, et al.
Journal of Clinical Pharmacology|December 23, 2024
Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5-HT<sub>3</sub> Antagonist Antiemetic DrugsLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Kidney International|February 8, 2025
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse modelSarah C Asby, Lauren E Thompson, Michael Goedken, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Nephrotoxicity of Immune Checkpoint Inhibitors in Mice with a Human Immune SystemSarah Asby, Xia Wen, Michael Goedken, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
The ISME Journal|December 17, 2014
Correlates of virulence in a frog-killing fungal pathogen: evidence from a California amphibian declineJonah Piovia-Scott, Karen Pope, S Joy Worth, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Neurosurgical Focus|November 2, 2022
Outcomes following stereotactic radiosurgery for foramen magnum meningiomas: a single-center experience and systematic review of the literatureConstantine L Karras, Pavlos Texakalidis, Jeffrey Z Nie, et al.
Pharmacotherapy|March 16, 2005
Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical PharmacyAlan J Zillich, Joseph J Saseen, Renee M Dehart, et al.
International Journal of Molecular Sciences|November 27, 2024
Population Pharmacokinetic Model of Vitamin D<sub>3</sub> and Metabolites in Chronic Kidney Disease Patients with Vitamin D Insufficiency and DeficiencyStacey M Tuey, Avisek Ghimire, Serge Guzy, et al.
Journal of Clinical Microbiology|March 9, 2004
Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United StatesS Joy Milan, Kirsten A Hauge, Natalia E Kurepina, et al.
Journal of Clinical Pharmacology|June 9, 2022
The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney DiseaseStacey M Tuey, Linda Prebehalla, Amandla-Atilano Roque, et al.
Journal of Clinical Pharmacology|December 23, 2024
Population Pharmacokinetic Model of Platinum Disposition in Cancer Patients Receiving Cisplatin and Randomized to 5-HT<sub>3</sub> Antagonist Antiemetic DrugsLauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Kidney International|February 8, 2025
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse modelSarah C Asby, Lauren E Thompson, Michael Goedken, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Nephrotoxicity of Immune Checkpoint Inhibitors in Mice with a Human Immune SystemSarah Asby, Xia Wen, Michael Goedken, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
The ISME Journal|December 17, 2014
Correlates of virulence in a frog-killing fungal pathogen: evidence from a California amphibian declineJonah Piovia-Scott, Karen Pope, S Joy Worth, et al.
Pageof 19